🤯 Have you seen our AI stock pickers’ 2024 results? 84.62%! Grab November’s list now.Pick Stocks with AI

ADMA Biologics Inc (ADMA)

NASDAQ
Currency in USD
19.3700
+3.0600(+18.76%)
Closed
After Hours
19.3800+0.0100(+0.0516%)
ADMA Scorecard
Full Analysis
Net income is expected to grow this year
Unusual trading volume
Fair Value
Day's Range
18.240020.1800
52 wk Range
3.540021.1300
Prev. Close
16.31
Open
18.29
Day's Range
18.24-20.18
52 wk Range
3.54-21.13
Volume
11,737,821
Average Volume (3m)
5,293,321
1-Year Change
461.45%
Book Value / Share
Unlock
Fair Value
Unlock
Fair Value Upside
Unlock
ADMA Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
18.6460
Downside
-3.7377%
Members' Sentiments
Bearish
Bullish
ProTips
3 analysts have revised their earnings upwards for the upcoming period
Show more

ADMA Biologics Inc Company Profile

ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. The company offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. It develops a pipeline of plasma-derived therapeutics, including products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, it operates source plasma collection facilities. The company sells its products through independent distributors, drug wholesalers, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was incorporated in 2004 and is headquartered in Ramsey, New Jersey.

Employees
624

Compare ADMA to Peers and Sector

Metrics to compare
ADMA
Peers
Sector
Relationship
P/E Ratio
129.8x−6.6x−0.6x
PEG Ratio
0.73−0.120.00
Price/Book
24.0x3.0x2.6x
Price / LTM Sales
13.7x18.2x3.2x
Upside (Analyst Target)
−7.1%110.2%48.9%
Fair Value Upside
Unlock16.7%7.2%Unlock

People Also Watch

26.90
TGTX
+7.34%
66.60
BMRN
+1.08%
76.13
INCY
+2.71%
46.22
IOT
-3.29%
34.12
EXEL
+2.77%

FAQ

What Is the ADMA Biologics Inc (ADMA) Stock Price Today?

The ADMA Biologics Inc stock price today is 19.37

What Stock Exchange Does ADMA Biologics Inc Trade On?

ADMA Biologics Inc is listed and trades on the NASDAQ stock exchange.

What Is the Stock Symbol for ADMA Biologics Inc?

The stock symbol for ADMA Biologics Inc is "ADMA."

What Is the ADMA Biologics Inc Market Cap?

As of today, ADMA Biologics Inc market cap is 4.51B.

What is ADMA Biologics Inc Earnings Per Share?

The ADMA Biologics Inc EPS is 0.152.

What Is the Next ADMA Biologics Inc Earnings Date?

ADMA Biologics Inc will release its next earnings report on Mar 20, 2025.

From a Technical Analysis Perspective, Is ADMA a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.